BAMCO Inc
BHVN

BAMCO Inc’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

BAMCO Inc’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-197,980
Closed -$27.3M – 433
2021
Q4 		$27.3M Buy
197,980
+85,463
+76% +$10.9M 0.06% 230
2021
Q3 		$15.6M Sell
112,517
-33,483
-23% -$4.18M 0.04% 275
2021
Q2 		$14.2M Hold
146,000
– – 0.03% 277
2021
Q1 		$9.98M Sell
146,000
-12,675
-8% -$1.03M 0.02% 289
2020
Q4 		$13.6M Buy
158,675
+4,400
+3% +$373K 0.03% 257
2020
Q3 		$10M Buy
154,275
+2,900
+2% +$190K 0.03% 247
2020
Q2 		$11.1M Hold
151,375
– – 0.04% 218
2020
Q1 		$5.15M Buy
151,375
+147,075
+3,420% +$6.72M 0.03% 238
2019
Q4 		$234K Buy
+4,300
New +$213K ﹤0.01% 314

Other funds holding BHVN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $153M AUM 42.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return